Keywords: zeneca, zomig, approved, additional, countries, pharmaceuticals, been

Zeneca's Zomig Approved In Additional Countries

Article | 18 August 1997

- Zeneca Pharmaceuticals has been granted clearance to market its5-HT1B/1D receptor antagonist Zomig (zolmitriptan) in Germany, Denmark and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in